Pulmonary function testing (PFT) is a critical tool in the diagnosis and management of respiratory conditions. Understanding the nuances of PFT interpretation is crucial for healthcare professionals to provide optimal patient care. This article aims to elucidate the essentials of interpreting these tests.
PFTs evaluate the respiratory system's functionality, including lung volume, capacity, rates of flow, and gas exchange. These tests can identify restrictive and obstructive lung diseases, differentiate between them, and assess their severity. PFTs include spirometry, lung volume tests, and diffusion capacity tests.
Spirometry measures the volume and flow of air that can be inhaled and exhaled. The forced vital capacity (FVC) and forced expiratory volume in 1 second (FEV1) are key measures. An FEV1/FVC ratio less than 0.7 indicates obstructive disease. A reduced FVC suggests restrictive disease.
Lung volume tests measure the total amount of air lungs can hold. They help differentiate between obstructive and restrictive diseases when spirometry results are inconclusive. Increased total lung capacity (TLC) suggests obstructive disease, while decreased TLC indicates restrictive disease.
These tests assess the lungs' efficiency in transferring gas from inhaled air to red blood cells. A reduced diffusion capacity can indicate interstitial lung disease, pulmonary hypertension, or emphysema.
Interpreting PFTs is a complex task requiring a solid understanding of the underlying physiological principles. The correct interpretation can guide diagnosis, influence treatment decisions, and monitor disease progression. Continuous education and practice are essential for healthcare professionals to master this critical skill.
1.
High Rate of Surgical Success in Complex NSCLC With Neoadjuvant Chemoimmunotherapy
2.
Papillary thyroid cancer: New markers offer hope for tailored treatment
3.
What Comes After Cancer?
4.
FDA Expands Durvalumab Label to Operable Lung Cancer
5.
In postmenopausal women with hormone receptor-positive tumors, obesity increases the risk of breast cancer recurrence.
1.
Finding Support: Connecting with the Vitiligo Community
2.
Essential Updates in Hematology in Daily Practice
3.
Neoepitope Vaccines in Oncology: Precision, Sequencing, and Immunotherapy Frontiers
4.
Living Better With Advanced Cancer Through Supportive Care
5.
Understanding Epoetin and Its Role in Treating Chronic Kidney Disease
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
2.
Updates on Standard V/S High Risk Myeloma Treatment
3.
What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?
4.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases - Part II
5.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation